A single administration of glucocorticoid increases exercise capacity in men with stable chronic obstructive pulmonary disease.

CONCLUSION: Our finding suggests that COPD patients experience improvements in exercise tolerance from a single high dose of glucocorticoid even in the stable phase of their disease. FUNDING: none. TRIAL REGISTRATION: EudraCT 2012-004503-13. PMID: 30573004 [PubMed - in process]
Source: Danish Medical Journal - Category: General Medicine Tags: Dan Med J Source Type: research